Skip to main content

Together we are beating cancer

Donate now

Cancer News

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 3487 results
An image of a capsule sponge, a test for Barrett's oesophagus and oesophageal cancer

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

by Tim Gunn | Analysis | 11 January 2024

11 January 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Bacterial microbiome mapping. Orange lines making connections and overlapping each other.

The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia. The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia.

by Sophie Wedekind | Analysis | 3 January 2024

3 January 2024

Two researchers smiling as they work together in a lab

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

by Jacob Smith | In depth | 18 December 2023

18 December 2023

A cloud of smoke from a cigarette

The decline in smoking prevalence in England has nearly ground to a halt since the start of the pandemic, according to a new study The decline in smoking prevalence in England has nearly ground to a halt since the start of the pandemic, according to a new study

by Jacob Smith | News | 14 December 2023

14 December 2023

The International Agency for Research on Cancer's (IARC's) website, seen on a phone and a computer.

The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us. The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us.

by Tim Gunn, Sophie Brooks | News | 11 December 2023

11 December 2023

That Cancer Conversation in a white speech bubble with a dark blue background

In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves.  In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves. 

by Cancer Research UK | Podcast | 27 November 2023

27 November 2023

This entry is part 12 of 38 in the series That Cancer Conversation
%postcontent%
A GP examining a patient.

Why do some cancers, and some groups of people, tend to be diagnosed later? Here's our investigation into inequalities in early diagnosis. Why do some cancers, and some groups of people, tend to be diagnosed later? Here's our investigation into inequalities in early diagnosis.

by Hope Walters | In depth | 23 November 2023

23 November 2023

This entry is part 5 of 5 in the series Health inequalities
%postcontent%
A stack of cigarettes, one of them smoking

The results of a new study funded by Cancer Research UK reveal that 1.3 million lives are lost to cancers caused by smoking tobacco every year across the UK, US and BRICS nations The results of a new study funded by Cancer Research UK reveal that 1.3 million lives are lost to cancers caused by smoking tobacco every year across the UK, US and BRICS nations

by Jacob Smith | News | 16 November 2023

16 November 2023